Spinaci, A.; Buccioni, M.; Catarzi, D.; Cui, C.; Colotta, V.; Dal Ben, D.; Cescon, E.; Francucci, B.; Grieco, I.; Lambertucci, C.;
et al. “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals 2023, 16, 167.
https://doi.org/10.3390/ph16020167
AMA Style
Spinaci A, Buccioni M, Catarzi D, Cui C, Colotta V, Dal Ben D, Cescon E, Francucci B, Grieco I, Lambertucci C,
et al. “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals. 2023; 16(2):167.
https://doi.org/10.3390/ph16020167
Chicago/Turabian Style
Spinaci, Andrea, Michela Buccioni, Daniela Catarzi, Chang Cui, Vittoria Colotta, Diego Dal Ben, Eleonora Cescon, Beatrice Francucci, Ilenia Grieco, Catia Lambertucci,
and et al. 2023. "“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies" Pharmaceuticals 16, no. 2: 167.
https://doi.org/10.3390/ph16020167
APA Style
Spinaci, A., Buccioni, M., Catarzi, D., Cui, C., Colotta, V., Dal Ben, D., Cescon, E., Francucci, B., Grieco, I., Lambertucci, C., Marucci, G., Bassani, D., Pavan, M., Varano, F., Federico, S., Spalluto, G., Moro, S., & Volpini, R.
(2023). “Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals, 16(2), 167.
https://doi.org/10.3390/ph16020167